These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27546046)

  • 21. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
    Nikitina T; Shi X; Ghosh RP; Horowitz-Scherer RA; Hansen JC; Woodcock CL
    Mol Cell Biol; 2007 Feb; 27(3):864-77. PubMed ID: 17101771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site.
    Claveria-Gimeno R; Lanuza PM; Morales-Chueca I; Jorge-Torres OC; Vega S; Abian O; Esteller M; Velazquez-Campoy A
    Sci Rep; 2017 Jan; 7():41635. PubMed ID: 28139759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics.
    Kleefstra T; Yntema HG; Nillesen WM; Oudakker AR; Mullaart RA; Geerdink N; van Bokhoven H; de Vries BB; Sistermans EA; Hamel BC
    Eur J Hum Genet; 2004 Jan; 12(1):24-8. PubMed ID: 14560307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
    Wong VC; Li SY
    J Child Neurol; 2007 Dec; 22(12):1397-400. PubMed ID: 18174559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MeCP2 Rett mutations affect large scale chromatin organization.
    Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
    Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-targeted specificity of the DNA binding proteins R.DpnI and MeCP2 studied by molecular dynamics simulations.
    Shanak S; Ulucan O; Helms V
    J Mol Model; 2017 May; 23(5):152. PubMed ID: 28374217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MECP2, a multi-talented modulator of chromatin architecture.
    Della Ragione F; Vacca M; Fioriniello S; Pepe G; D'Esposito M
    Brief Funct Genomics; 2016 Nov; 15(6):420-431. PubMed ID: 27296483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
    Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
    Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
    PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MeCP2 in central nervous system glial cells: current updates.
    Sharma K; Singh J; Frost EE; Pillai PP
    Acta Neurobiol Exp (Wars); 2018; 78(1):30-40. PubMed ID: 29694339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MECP2 gene mutation screening in Rett syndrome patients from Croatia.
    Matijević T; Knezević J; Barisić I; Resić B; Culić V; Pavelić J
    Ann N Y Acad Sci; 2006 Dec; 1091():225-32. PubMed ID: 17341617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative investigation of the effects of DNA modifications and protein mutations on MeCP2-MBD-DNA interactions.
    Wang Q; Luo S; Xiong D; Xu X; Zhao X; Duan L
    Int J Biol Macromol; 2023 Aug; 247():125690. PubMed ID: 37423448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classic Rett syndrome in a boy with R133C mutation of MECP2.
    Masuyama T; Matsuo M; Jing JJ; Tabara Y; Kitsuki K; Yamagata H; Kan Y; Miki T; Ishii K; Kondo I
    Brain Dev; 2005 Sep; 27(6):439-42. PubMed ID: 16122633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.